Cost Effectiveness and Resource Allocation

Papers
(The H4-Index of Cost Effectiveness and Resource Allocation is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds36
Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985—202324
Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran21
What makes inequality in the area of dental and oral health in developing countries? A scoping review21
Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making20
Strategies for reducing out of pocket payments in the health system: a scoping review19
Examination on level of scale efficiency in public hospitals in Tanzania18
Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis18
Level and determinants of county health system technical efficiency in Kenya: two stage data envelopment analysis16
First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis16
Health technology assessment of medical devices: current landscape, challenges, and a way forward15
Household catastrophic health expenditure and its effective factors: a case of Iran15
Cost-effectiveness analysis of text messaging to support health advice for smoking cessation15
Market access and value-based pricing of digital health applications in Germany14
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma14
0.041595220565796